Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium: An Age-Stratified Study.

Authors:
Yan S; Wu H; Yu Y; Li N; Yu L and 4 more

Journal:
Pain Ther

Publication Year: 2023

DOI:
10.1007/s40122-023-00490-5

PMCID:
PMC10199981

PMID:
36884108

Journal Information

Full Title: Pain Ther

Abbreviation: Pain Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures All the authors, Shiting Yan, Hao Wu, Yanlong Yu, Ning Li, Leyang Yu, Ying Wang, Hu Li, Dongsheng Zhang, and Zhuan Zhang, declare that they have no conflicts of interest."

Evidence found in paper:

"Funding The study was funded by Beijing Medical Award Foundation Key Project (No. YXJL-2021-0307-0632) and the Social Development Project of Yangzhou Science and Technology Bureau (No. YZ2022108) from Dr. Zhuan Zhang. No funding or sponsorship was received for this study or publication of this article. The Rapid Service Fee was funded by the authors."

Evidence found in paper:

"Trial Registration ClinicalTrials.gov: NCT05217238 (registration date 18 Dec 2021)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025